Andre Sadler
Laboratory Coordinator
Last active: 11/15/2012

  1. Abnormal mitochondrial bioenergetics and heart rate dysfunction in mice lacking very-long-chain acyl-CoA dehydrogenase. Exil VJ, Gardner CD, Rottman JN, Sims H, Bartelds B, Khuchua Z, Sindhal R, Ni G, Strauss AW (2006) Am J Physiol Heart Circ Physiol 290(3): H1289-97
    › Primary publication · 16199475 (PubMed)
  2. Rapid stimulation causes electrical remodeling in cultured atrial myocytes. Yang Z, Shen W, Rottman JN, Wikswo JP, Murray KT (2005) J Mol Cell Cardiol 38(2): 299-308
    › Primary publication · 15698836 (PubMed)
  3. Partial gene deletion of heart-type fatty acid-binding protein limits the severity of dietary-induced insulin resistance. Shearer J, Fueger PT, Bracy DP, Wasserman DH, Rottman JN (2005) Diabetes 54(11): 3133-9
    › Primary publication · 16249436 (PubMed)
  4. Organ-specific roles for transcription factor NF-kappaB in reovirus-induced apoptosis and disease. O'Donnell SM, Hansberger MW, Connolly JL, Chappell JD, Watson MJ, Pierce JM, Wetzel JD, Han W, Barton ES, Forrest JC, Valyi-Nagy T, Yull FE, Blackwell TS, Rottman JN, Sherry B, Dermody TS (2005) J Clin Invest 115(9): 2341-50
    › Primary publication · 16100570 (PubMed) · PMC1184036 (PubMed Central)
  5. Hexokinase II protein content is a determinant of exercise endurance capacity in the mouse. Fueger PT, Shearer J, Krueger TM, Posey KA, Bracy DP, Heikkinen S, Laakso M, Rottman JN, Wasserman DH (2005) J Physiol 566(Pt 2): 533-41
    › Primary publication · 15878951 (PubMed) · PMC1464755 (PubMed Central)
  6. Heart-type fatty acid-binding protein reciprocally regulates glucose and fatty acid utilization during exercise. Shearer J, Fueger PT, Rottman JN, Bracy DP, Binas B, Wasserman DH (2005) Am J Physiol Endocrinol Metab 288(2): E292-7
    › Primary publication · 15454399 (PubMed)
  7. Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice. Mounkes LC, Kozlov SV, Rottman JN, Stewart CL (2005) Hum Mol Genet 14(15): 2167-80
    › Primary publication · 15972724 (PubMed)
  8. Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM. Murray KT, Rottman JN, Arbogast PG, Shemanski L, Primm RK, Campbell WB, Solomon AJ, Olgin JE, Wilson MJ, Dimarco JP, Beckman KJ, Dennish G, Naccarelli GV, Ray WA, AFFIRM Investigators (2004) Heart Rhythm 1(6): 669-75
    › Primary publication · 15851238 (PubMed)
  9. Implantable cardioverter-defibrillator malfunction due to mechanical failure of the header connection. Pickett RA, Saavedra P, Ali MF, Darbar D, Rottman JN (2004) J Cardiovasc Electrophysiol 15(9): 1095-9
    › Primary publication · 15363086 (PubMed)
  10. AMPK stimulation increases LCFA but not glucose clearance in cardiac muscle in vivo. Shearer J, Fueger PT, Rottman JN, Bracy DP, Martin PH, Wasserman DH (2004) Am J Physiol Endocrinol Metab 287(5): E871-7
    › Primary publication · 15265760 (PubMed)